p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. - Wikidata - awgldk - TriplyDB

p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats.

p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats.

http://www.wikidata.org/entity/Q34411966

about

Nitric oxide and peroxynitrite in health and disease Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training Air pollution exposure potentiates hypertension through reactive oxygen species-mediated activation of Rho/ROCK Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle Nitric oxide synthase-dependent responses of the basilar artery during acute infusion of nicotine Apocynin improves endothelial function and prevents the development of hypertension in fructose fed rat.NADPH oxidases in vascular pathology.Alcohol-induced hypertension: Mechanism and prevention.Redox signaling, vascular function, and hypertension.Redox control of vascular smooth muscle migration.Role for NADPH/NADH oxidase in the modulation of vascular tone.Asymmetric dimethylarginine in angiotensin II-induced hypertension Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease.Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats.Vascular oxidant stress: molecular mechanisms and pathophysiological implications.Free radical production and angiotensin.Tempol, a superoxide dismutase mimetic, prevents cerebral vessel remodeling in hypertensive rats.Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease.Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension.Reactive oxygen species: roles in blood pressure and kidney function.Reactive oxygen species cause endothelial dysfunction in chronic flow overload.Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?Role of superoxide dismutase in in vivo and in vitro nitrate tolerance Elevated oxidative stress and endothelial dysfunction in right coronary artery of right ventricular hypertrophy.Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice.Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system.Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(ω)-nitro-L-arginine methyl ester hypertensive rats.NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies.Vascular NAD(P)H oxidases: specific features, expression, and regulation.

P2860

Q24645400-DC85ED05-2A1D-42D9-B1B4-79D7EA67F79E Q24655588-9DE7C7AE-13B9-4C23-94FE-0869F3E17765 Q26766479-28E66E17-C57C-4300-AD1A-708352DFDDF1 Q26799354-887D2BB5-911F-4626-A35F-3E5C7E040A13 Q26799985-BDB1C55F-3CBD-4B80-8605-F84AF64512CF Q26865426-EF86A386-8B28-4964-9DBD-856F46D459B9 Q26991619-C1E6AE1E-4A32-48A8-9538-EC9A8423FF0F Q28080916-E1CD3BA8-87EA-4180-842B-F6A95FDC293E Q28145799-22775DEB-D4A1-4C17-BB2E-0489ACB744E0 Q28390943-153CEE85-68B6-42C5-8C3E-308EAD689910 Q28576951-69E9D67B-295E-4BF7-98FD-8435C961B0D1 Q28583958-E8F178CA-DDFF-40F0-A40B-3F82AEAC0A23 Q30486865-B3BF9FB3-5D1A-48A0-8093-CE4694CB1BFB Q33616184-65C38E73-6311-4D69-BAE3-E0B95BD203DA Q33632089-D7CDF472-F480-48B7-9A5F-9A2EEC06AFCA Q33686885-B10BD38B-55AA-40BE-A3B2-729584DF69BF Q33689229-DB48D032-84D1-45E1-9CC1-6E4CA463D742 Q33690103-AD189EB3-D8CF-4AEE-88B2-B6219AD7225A Q33692492-787825E9-A906-42AA-99BC-4AC0C3E20DEB Q33728163-09B6099E-30B9-4E8B-BCCC-40C33C2A150F Q33742717-3555440E-A9B7-46A7-9034-4CD13FBB7BA8 Q33764561-998F92B6-D36B-44AB-83DA-17E90ADBB937 Q33863119-08B0BFEF-1C82-46BC-9614-26A83232E73F Q33897671-0C23E355-38C3-4197-8A0B-929A711AE779 Q33957964-F4C8A759-3C0F-4451-AB8B-139F438610D7 Q34028489-418E3573-BBF6-419D-A1E5-3828B30F1B5B Q34311404-707C84FA-2923-4376-8DA8-2C55510E77B0 Q34479731-A5E4A36D-511F-4656-9490-BE3FD7AFC8E2 Q34506899-39E831D2-84D2-467F-A6EF-836DE457D582 Q34555173-014F6AF4-F9FD-44C6-B96B-DA87034401A3 Q34598465-D9316637-964E-4492-8441-F614E34E4AD3 Q34726868-4CA04A1E-B5F5-462E-902C-64072AAE6861 Q34766266-726B2774-2E59-4465-AA09-6E2CF0EBDB69 Q35029061-224B9B41-3E87-4E64-8ADC-D4C6331938FA Q35057093-F879100E-4659-4DCD-BFC4-833B78CC4943 Q35083693-B47330B4-0095-4B52-B0FB-77D6FBB99A2E Q35102845-FA6E7B43-A341-46C9-BFC5-62EAFD380E5E Q35120364-E684E02E-8F86-4CA0-BEBC-AB6CDEFE9B96 Q35145985-B46DF02F-E448-4DED-AA3A-427D6C08E4C7 Q35175526-700A88F0-A659-4E55-AD1B-EE7D069AAE68

P2860

p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats.

http://www.wikidata.org/entity/Q34411966

description

1997 nî lūn-bûn

@nan

1997 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

p22phox mRNA expression and NA ...... aortas from hypertensive rats.

@ast

p22phox mRNA expression and NA ...... aortas from hypertensive rats.

@en

p22phox mRNA expression and NA ...... aortas from hypertensive rats.

@nl

type

label

p22phox mRNA expression and NA ...... aortas from hypertensive rats.

@ast

p22phox mRNA expression and NA ...... aortas from hypertensive rats.

@en

p22phox mRNA expression and NA ...... aortas from hypertensive rats.

@nl

prefLabel

p22phox mRNA expression and NA ...... aortas from hypertensive rats.

@ast

p22phox mRNA expression and NA ...... aortas from hypertensive rats.

@en

p22phox mRNA expression and NA ...... aortas from hypertensive rats.

@nl

P1433

Q34411966-C243B42E-7805-4512-B8C0-8BC54DFD33D2

P1476

Q34411966-29646447-ECFB-44F4-899B-BA5500478F32

P2093

Q34411966-363D378B-E39A-4CFE-9295-8ACDFE5F6F28

Q34411966-3D01E98D-798E-4287-8BEC-27844CD1C5E1

Q34411966-4343E4CA-E156-4437-9B77-98E535F43FBA

Q34411966-6446BBD7-A674-4B2E-BA57-6416E7CC38FB

Q34411966-6494BF9F-1A09-4471-AF80-386E479845B9

Q34411966-6D44ED39-51DA-4121-8C31-A032D0393CD7

Q34411966-99AC972A-1CBE-45A6-A436-8C38751E7948

Q34411966-A42A0391-98C5-4156-B71B-C60C3BEFF3BE

Q34411966-ADA15BA3-C344-4D8C-BBFB-D88551994A3F

Q34411966-B73912CF-F972-47C1-9EB3-674BFCF5AC0B

P304

Q34411966-46D550AA-4DB4-4364-80C9-4FF2A46AAF6B

P31

Q34411966-E56817CF-3A4B-43E0-9B97-F6E54F00A174

P356

Q34411966-4BBFF3CC-1689-43E9-8E4D-2D0C275D84EF

P433

Q34411966-5643DA59-08E7-41C3-9A33-598BFBC518A3

P478

Q34411966-6BD2C280-B7A2-4F30-B18B-B844BAF744D0

P577

Q34411966-D86DB0E2-FD2F-4A77-8670-E5AFEFB93DD9

P698

Q34411966-09269D94-B10D-47E9-A0E8-68A87049F16D

P921

Q34411966-9F63009B-EAFC-443A-B448-5BFF7256E138

P356

P1433

Circulation Research

P1476

p22phox mRNA expression and NA ...... aortas from hypertensive rats.

@en

P2093

Capers Q 4th

http://www.w3.org/2001/XMLSchema#string

Fukui T

http://www.w3.org/2001/XMLSchema#string

Griendling KK

http://www.w3.org/2001/XMLSchema#string

Harrison DG

http://www.w3.org/2001/XMLSchema#string

Ishizaka N

http://www.w3.org/2001/XMLSchema#string

Laursen JB

http://www.w3.org/2001/XMLSchema#string

Rajagopalan S

http://www.w3.org/2001/XMLSchema#string

Taylor WR

http://www.w3.org/2001/XMLSchema#string

Wilcox JN

http://www.w3.org/2001/XMLSchema#string

de Leon H

http://www.w3.org/2001/XMLSchema#string

P304

45-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.RES.80.1.45

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8978321

http://www.w3.org/2001/XMLSchema#string

P921